Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole

NCT01468558 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: MAP0004
DRUG: IV DHE
DRUG: Ketoconazole

Sponsor

Allergan

Collaborators

[object Object]